fluorodeoxyglucose f18 has been researched along with Rheumatic Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arumalla, N; Bhuva, S; Cope, A; D'Cruz, D; Subesinghe, M; Subesinghe, S | 1 |
| Betrains, A; Blockmans, D; De Langhe, E; Moreel, L; Vanderschueren, S | 1 |
| Aochi, S; Uehara, M; Yamamoto, M | 1 |
| Galloway, J; Mabey, E; Rutherford, A | 1 |
| Kubota, K; Mimori, A; Yamashita, H | 1 |
| Watts, RA | 1 |
| Del Biondo, E; Knockaert, DD; Ruttens, D; Van Boxelaer, I; Vanderschueren, S; Wauters, E | 1 |
| Backhaus, M; Sandrock, D | 1 |
| Duet, M; Faraggi, M; Lioté, F; Pouchot, J | 1 |
6 review(s) available for fluorodeoxyglucose f18 and Rheumatic Diseases
| Article | Year |
|---|---|
2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rheumatic Diseases | 2022 |
Rheumatic disorders among patients with fever of unknown origin: A systematic review and meta-analysis.
Topics: Adult; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Prospective Studies; Retrospective Studies; Rheumatic Diseases | 2022 |
Differentiating Disease Flare From Infection: A Common Problem in Rheumatology. Do 18F-FDG PET/CT Scans and Novel Biomarkers Hold The Answer?
Topics: Biomarkers; Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Positron Emission Tomography Computed Tomography; Rheumatic Diseases; Still's Disease, Adult-Onset; Vasculitis | 2018 |
Clinical value of whole-body PET/CT in patients with active rheumatic diseases.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Rheumatic Diseases; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
How to investigate multisystem disease.
Topics: Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography; Rheumatic Diseases; Tomography, X-Ray Computed | 2014 |
Role for positron emission tomography in skeletal diseases.
Topics: Arthritis; Bone Diseases; Bone Diseases, Infectious; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rheumatic Diseases; Sensitivity and Specificity; Vasculitis | 2007 |
3 other study(ies) available for fluorodeoxyglucose f18 and Rheumatic Diseases
| Article | Year |
|---|---|
IgG4-related Disease Emerging after COVID-19 mRNA Vaccination.
Topics: Aged; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G4-Related Disease; Rheumatic Diseases; United States; Vaccination | 2023 |
Inflammation of unknown origin versus fever of unknown origin: two of a kind.
Topics: Adult; Aged; C-Reactive Protein; Databases, Factual; Diagnosis-Related Groups; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infections; Inflammation; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Rheumatic Diseases | 2009 |
[Imaging techniques in rheumatology: PET in rheumatology].
Topics: Fluorodeoxyglucose F18; Humans; Image Enhancement; Joints; Positron-Emission Tomography; Radiopharmaceuticals; Rheumatic Diseases; Rheumatology | 2010 |